Harnessing natural killer cell effector function against cancer
Immunotherapy Advances · 01.01.2024 · 4 (1)
DOI: 10.1093/immadv/ltad031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 21.12.2023. Verfasst von Matthew D Blunt und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council.
Abstract (Originalsprache)
Natural killer (NK) cells are cytotoxic innate lymphoid cells that participate in anti-tumour and anti-viral immune responses. Their ability to rapidly destroy abnormal cells and to enhance the anti-cancer function of dendritic cells, CD8+ T cells, and macrophages makes them an attractive target for immunotherapeutic strategies. The development of approaches that augment NK-cell activation against cancer is currently under intense preclinical and clinical research and strategies include chimeric antigen receptor NK cells, NK-cell engagers, cytokines, and immune checkpoint inhibitors. In this review, we highlight recent advances in NK-cell therapeutic development and discuss their potential to add to our armamentarium against cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
ORCID-Profile: Matthew D Blunt
Förderung
- Cancer Research UK
- Medical Research Council
Zitieren
APA
Blunt, M. D., & Khakoo, S. I. (2024). Harnessing natural killer cell effector function against cancer. Immunotherapy Advances, 4(1). https://doi.org/10.1093/immadv/ltad031
Vancouver
Blunt MD, Khakoo SI. Harnessing natural killer cell effector function against cancer. Immunotherapy Advances. 2024;4(1). doi:10.1093/immadv/ltad031
BibTeX
@article{Blunt2024,
author = {Blunt, Matthew D and Khakoo, Salim I},
title = {Harnessing natural killer cell effector function against cancer},
journal = {Immunotherapy Advances},
year = {2024},
volume = {4},
number = {1},
doi = {10.1093/immadv/ltad031}
}
EUVIMED